[Streptokinase-streptodornase association, a powerful therapeutic agent affecting the venous factor in obliterating arteritis of the lower limbs].
D000368:Aged; D001167:Arteritis / Q000188:drug therapy; D003851:Deoxyribonucleases / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D013299:Streptodornase and Streptokinase; D003851:Deoxyribonucleases; D013300:Streptokinase
L'association streptokinase-streptodornase agent thérapeutique puissant sur le facteur veineux des artérites oblitérantes des membres inférieurs.